Literature DB >> 27756530

Modulating Antibody Functionality in Infectious Disease and Vaccination.

Bronwyn M Gunn1, Galit Alter2.   

Abstract

Induction of pathogen-specific binding antibodies has long been considered a signature of protective immunity following vaccination and infection. The humoral immune response is a complex network of antibodies that target different specificities and drive different functions, collectively acting to limit and clear infection either directly, via pathogen neutralization, or indirectly, via pathogen clearance by the innate immune system. Emerging data suggest that not all antibody responses are equal, and qualitative features of antibodies may be key to defining protective immune profiles. Here, we review the most recent advances in our understanding of protective functional antibody responses in natural infection, vaccination, and monoclonal antibody therapeutics. Moreover, we highlight opportunities to augment or modulate antibody-mediated protection through enhancement of antibody functionality.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  ADCC; Fc receptors; HIV; antibodies; antibody glycosylation; vaccination

Mesh:

Substances:

Year:  2016        PMID: 27756530      PMCID: PMC8767654          DOI: 10.1016/j.molmed.2016.09.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  102 in total

Review 1.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

2.  Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity.

Authors:  Stylianos Bournazos; Siu-Kei Chow; Nareen Abboud; Arturo Casadevall; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

3.  Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

Authors:  R A Clynes; T L Towers; L G Presta; J V Ravetch
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Restoration of tolerance in lupus by targeted inhibitory receptor expression.

Authors:  Tracy L McGaha; Brian Sorrentino; Jeffrey V Ravetch
Journal:  Science       Date:  2005-01-28       Impact factor: 47.728

5.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

Review 6.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.

Authors:  Maria G Guzman; Mayling Alvarez; Scott B Halstead
Journal:  Arch Virol       Date:  2013-03-08       Impact factor: 2.574

7.  Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.

Authors:  Stylianos Bournazos; Florian Klein; John Pietzsch; Michael S Seaman; Michel C Nussenzweig; Jeffrey V Ravetch
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

8.  IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.

Authors:  Sanne E de Jong; Maurice H J Selman; Ayola A Adegnika; Abena S Amoah; Elly van Riet; Yvonne C M Kruize; John G Raynes; Alejandro Rodriguez; Daniel Boakye; Erika von Mutius; André C Knulst; Jon Genuneit; Philip J Cooper; Cornelis H Hokke; Manfred Wuhrer; Maria Yazdanbakhsh
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

9.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

10.  Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.

Authors:  Yuhsuke Ohmi; Wataru Ise; Akira Harazono; Daisuke Takakura; Hidehiro Fukuyama; Yoshihiro Baba; Masashi Narazaki; Hirofumi Shoda; Nobunori Takahashi; Yuki Ohkawa; Shuting Ji; Fumihiro Sugiyama; Keishi Fujio; Atsushi Kumanogoh; Kazuhiko Yamamoto; Nana Kawasaki; Tomohiro Kurosaki; Yoshimasa Takahashi; Koichi Furukawa
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  33 in total

1.  Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.

Authors:  J Brian Kimble; Delphine C Malherbe; Michelle Meyer; Bronwyn M Gunn; Marcus M Karim; Philipp A Ilinykh; Mathieu Iampietro; Khaled S Mohamed; Surendra Negi; Pavlo Gilchuk; Kai Huang; Yuri I Wolf; Werner Braun; James E Crowe; Galit Alter; Alexander Bukreyev
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Nirmin Alsahafi; Jonathan Richard; Jérémie Prévost; Mathieu Coutu; Nathalie Brassard; Matthew S Parsons; Daniel E Kaufmann; Mark Brockman; Andrés Finzi
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.

Authors:  Jairo A Fonseca; Jessica N McCaffery; Juan Caceres; Elena Kashentseva; Balwan Singh; Igor P Dmitriev; David T Curiel; Alberto Moreno
Journal:  Vaccine       Date:  2018-04-12       Impact factor: 3.641

4.  Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.

Authors:  Anna-Barbara Moscicki; Brad Karalius; Katherine Tassiopoulos; Tzy-Jyun Yao; Denise L Jacobson; Kunjal Patel; Murli Purswani; George R Seage
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

5.  Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.

Authors:  Joseph R Francica; Daniel E Zak; Caitlyn Linde; Emilio Siena; Carrie Johnson; Michal Juraska; Nicole L Yates; Bronwyn Gunn; Ennio De Gregorio; Barbara J Flynn; Nicholas M Valiante; Padma Malyala; Susan W Barnett; Pampi Sarkar; Manmohan Singh; Siddhartha Jain; Margaret Ackerman; Munir Alam; Guido Ferrari; Andres Salazar; Georgia D Tomaras; Derek T O'Hagan; Alan Aderem; Galit Alter; Robert A Seder
Journal:  Blood Adv       Date:  2017-11-17

6.  Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.

Authors:  Carolyn M Boudreau; Wen-Han Yu; Todd J Suscovich; H Keipp Talbot; Kathryn M Edwards; Galit Alter
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Authors:  Shariq Mujib; Jun Liu; A K M Nur-Ur Rahman; Jordan A Schwartz; Phil Bonner; Feng Yun Yue; Mario A Ostrowski
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 8.  Toward the Cure of HIV-1 Infection: Lessons Learned and Yet to be Learned as New Strategies are Developed.

Authors:  Jeffrey M Jacobson; Kamel Khalili
Journal:  AIDS Rev       Date:  2018       Impact factor: 2.500

9.  Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Authors:  Marta Vidal; Ruth Aguilar; Joseph J Campo; Carlota Dobaño
Journal:  J Immunol Methods       Date:  2018-01-31       Impact factor: 2.303

10.  Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.

Authors:  Hao Li; Xing-Xing Wang; Bin Wang; Lei Fu; Guan Liu; Yu Lu; Min Cao; Hairong Huang; Babak Javid
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.